Upon receiving her master's degree, columnist Desiree Lama reflects on how her parents have supported her while she's living ...

RRMS patients started on high-efficacy treatments may have less reduction in work capacity than those on moderate-efficacy ...

The PoNS device has shown significant benefits in walking and balance in clinical trials, and benefits were seen in ...

The number of mitochondrial DNA copies may drop as MS progresses, suggesting a possible biomarker for disease progression, a ...

Quantum Biopharma plans to file an application by year's end seeking FDA clearance for a Phase 2 clinical trial testing Lucid ...

Higher levels of a type of bacteria called Lachnospiraceae in the gut may be a key risk factor for multiple sclerosis (MS), ...

It may be largely invisible to others, but the cognitive fog associated with MS can be difficult to manage, says columnist.

Copaxone and generic versions of glatiramer acetate are injected under the skin at 20 mg/mL daily or 40 mg/mL three times a ...

Worsening disability may increase the risk of bone mineral density loss in MS, potentially leading to fractures, a study ...

Levels of B-cells can help to predict the risk of disability progression independent of relapse activity in relapsing MS ...

People with MS who experience progression independent of relapse activity tend to have more damage to their brain's white ...

A holistic 12-week therapy program based on the Wim Hof method was seen to help ease cognitive fatigue and other MS symptoms in a pilot study.